Journal: Endocrinology

Article Title: Posttranslational activation of bone morphogenetic protein 2 is mediated by proprotein convertase 6 during decidualization for pregnancy establishment.

doi: 10.1210/en.2010-0326

Figure Lengend Snippet: FIG. 4. Proteolytic cleavage of BMP2 during decidualization and its inhibition by Poly R. A, Schematic diagram showing that BMP2 protein is initially synthesized as an inactive precursor, which is then cleaved at the KREKR2822 site to release the C-terminal mature ligand. B, Western analysis of different forms of BMP2 protein (precursor, 44 kDa; mature homodimeric form,26 kDa) in lysates of HESCs after no treatment (ND), decidualization (D), or decidualization in the presence of 10 M Poly R (DPoly R) for 72 h. C, The levels of secreted active BMP2 in the conditioned media measured by ELISA. The data are expressed as fold changes relative to ND. Values are means SEM for three experiments. *, P 0.05.

Article Snippet: To determine whether active recombinant (r) BMP2 would rescue some of the decidualization arrest caused by Poly R, HESCs were decidualized in the presence of 10 M Poly R without or with active recombinant human BMP2 (rBMP2; 50–5000 pg/ml; R&D Systems) for 72 h. The extent of decidualization was compared among the treatments by ELISA for PRL in the conditioned media.

Techniques: Inhibition, Synthesized, Western Blot, Enzyme-linked Immunosorbent Assay

Journal: Endocrinology

Article Title: Posttranslational activation of bone morphogenetic protein 2 is mediated by proprotein convertase 6 during decidualization for pregnancy establishment.

doi: 10.1210/en.2010-0326

Figure Lengend Snippet: FIG. 5. Proteolytic processing of BMP2 by PC6 in vitro. A and B, A 16-mer peptide (wild type), GHPLHKREKR2QAKHKQ containing the processing site of BMP2 (KREKR2822), was incubated in the absence (PC6, A) or presence (PC6, B) of 5 U of recombinant PC6 for 24 h, and the cleavage products were analyzed by SELDI mass spectrometry. The peptide (2020 m/z) was cleaved at the predicted site by PC6, producing a smaller peptide of expected size (1300 m/z). Spectra C and D are similar to A and B, except the peptide was mutated in which the amino acids KREKR were replaced by AAAAA. PC6 failed to cleave the mutant peptide because a similar profile was detected in the absence (C) or presence (D) of PC6 with no cleaved products.

Article Snippet: To determine whether active recombinant (r) BMP2 would rescue some of the decidualization arrest caused by Poly R, HESCs were decidualized in the presence of 10 M Poly R without or with active recombinant human BMP2 (rBMP2; 50–5000 pg/ml; R&D Systems) for 72 h. The extent of decidualization was compared among the treatments by ELISA for PRL in the conditioned media.

Techniques: In Vitro, Incubation, Recombinant, Mass Spectrometry, Mutagenesis

Journal: Endocrinology

Article Title: Posttranslational activation of bone morphogenetic protein 2 is mediated by proprotein convertase 6 during decidualization for pregnancy establishment.

doi: 10.1210/en.2010-0326

Figure Lengend Snippet: FIG. 6. Partial rescue of decidualization arrest caused by PC6 inhibition by Poly R. HESCs were decidualized in the presence of 10 M Poly R (inhibition) together with various doses of recombinant active BMP2 (inhibitionrBMP2) for 72 h. The extent of decidualization was determined by ELISA measurement of decidual marker PRL levels in the culture medium. The data are expressed as percentage changes relative to Poly R inhibition. Each value represents mean SEM of three separate experiments. *, P 0.05.

Article Snippet: To determine whether active recombinant (r) BMP2 would rescue some of the decidualization arrest caused by Poly R, HESCs were decidualized in the presence of 10 M Poly R without or with active recombinant human BMP2 (rBMP2; 50–5000 pg/ml; R&D Systems) for 72 h. The extent of decidualization was compared among the treatments by ELISA for PRL in the conditioned media.

Techniques: Inhibition, Recombinant, Enzyme-linked Immunosorbent Assay, Marker

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A,B,C) Schematic of constructs used here to activate FGF (A), BMP (B), and Nodal (C) signaling. Myr = myristoylation motif, GS = glycine/serine linker, LOV = light oxygen voltage-sensing domain, HA = hemagglutinin tag, FLAG = FLAG epitope. The single-transcript bOpto-2A-Nodal construct (C) follows the same design as -FGF and -BMP, except the type I (Acvr1ba) and type II (Acvr2ba) components are connected via a 2A peptide sequence (gray). A’,B’,C’) Optogenetic strategy to activate FGF (A’), BMP (B’), and Nodal (C’) signaling. Blue light-dimerizing LOV domains are fused to myristoylated receptor kinase domains. Blue light exposure should lead to receptor kinase interactions, signaling effector phosphorylation, and activation of target genes.

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Construct, FLAG-tag, Sequencing, Phospho-proteomics, Activation Assay

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Measured spectra for A) the 455 nm light used in uniform blue light exposure experiments (all figures except ), B) the 495+ nm used in and Supp. Figs. 2, 3, 4, & 12, and C) the 600 nm light source used to avoid inadvertent signaling activation during handling of embryos expressing bOpto constructs.

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Activation Assay, Expressing, Construct

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A) Uninjected (-) embryos and embryos injected (+) at the one-cell stage with the indicated mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting ∼2 hours post-fertilization (hpf). Phenotypes were scored at 1 day post-fertilization (dpf) (N = 3; ; Mean +/- SD). B,C,D) Uninjected embryos and embryos injected with the indicated bOpto + GFP mRNA were exposed to dark, 495+ nm light, or 455 nm light starting at early gastrulation (50% epiboly - shield) for 30 min. HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). Scale bar is 200 µm. B’,C’,D’) Quantification of experiments shown in B,C,D. Linear-mixed model-predicted least squared means of GFP-normalized phosphorylated effector signal +/- SEM. D’ shows nuclear signal only. (N = 3, * indicates p < 0.05; & ).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A-C”) Uninjected embryos (-) and embryos injected (+) at the one-cell stage with the bOp- to-FGF (A-A”), bOpto-BMP (B-B”), or bOpto-2A-Nodal (C-C”) mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting 1.5-2 hours post-fertilization. Phenotypes were scored at 1 day post-fertilization. Individual repeats are shown. Numbers indicate the total number of embryos scored in each condition for that experiment. shows the combined data from these three repeats. Phenotype legend images shown here are the same images shown in .

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOp- to-BMP (B) , or bOpto-2A-Nodal (C) were exposed to 455 nm light (50 W/m 2 , bottom rows) or dark (top rows) for 2 hours starting before gastrulation (dome - 30% epiboly). Multiplexed HCR-FISH was used to detect expression of the indicated pathway target genes. (N = 3; Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection, Expressing

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOpto-BMP (B) , or bOpto-2A-Nodal (C) were exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) for 30 minutes starting at gastrulation (50% epiboly - shield). Triple IF was used to simultaneously detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; ; Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A-E) Embryos injected at the one-cell stage with mRNA encoding bOpto-2A-Nodal exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) starting at early gastrulation (50% epiboly - shield stage) for 30 min. Triple IF staining was used to simultaneously detect activated signaling effectors (pSmad1, ppERK, and pSmad2 reflecting BMP, FGF, and Nodal signaling, respectively). Only ppERK and pSmad2 shown here. Three bOpto-2A-Nodal-expressing embryos per condition from five experimental repeats are shown. (Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection, Staining, Expressing

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF , bOpto-BMP , or bOp- to-2A-Nodal . A,B,C) Starting at early gastrulation (50% epiboly - shield), embryos were either kept in the dark (top row) or exposed to 455 nm light (50 W/m 2 ) light for 30 min (bottom row) and fixed during and after exposure. HCR-IF was used to detect activated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; Scale bar is 200 µm). A’,B’,C’) Quantification of experiments shown in A-C. Signal was GFP-normalized and subtracted against dark time-matched controls (N = 3; each N indicated by matched shape; & ; Mean +/- SD; * indicates p < 0.05 when compared to time = 0 min). A’’- C’’, A’’’-C’’’) A three-parameter logistic regression was fit to the 0-30 min data (A’’-C’’) or the >= 30 min data (A’’’-C’’’). (N = 3; Mean +/- SD; Supplementary Materials; solid line represents predicted curve fit

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOp- to-FGF (A), bOpto-BMP (B), or bOpto-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed at different time points during and after exposure. HCR-IF staining used to detect activated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized voxel-wise based on co-injected GFP intensity shown here (see Supp. Fig. 7). GFP images correspond to representative IF images shown in . (Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection, Staining

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed during and after exposure. Three full repeats were performed across 3-5 trials. HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection, Staining

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A) Table of irradiance and corresponding light dosage values used in B-D’. B,C,D) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (B), bOpto-BMP (C), or bOpto-2A-Nodal (D). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light at the indicated irradiance for 5 min (bOp- to-FGF, B) or 25 min (bOpto-BMP and -2A-Nodal, C and D). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively; Scale bar is 200 µm). B’,C’,D’) Quantification of experiments in B-D. Signal was GFP-normalized and subtracted against dark controls. A three-parameter logistic regression was fit to the data. (N = 2-3; each N indicated by matched shape; Mean +/- SD; & ; solid line represents predicted curve fit +/- 95% CI; D’ shows nuclear signal only). Tables indicate goodness of fit (R 2 ), the predicted irradiance (with 95% CI) at which 20 (I 20 ), 50 (I 50 ), and 90% (I 90 ) of the curve’s upper asymptote is reached (Supplementary Materials).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A), bOpto-BMP (B), or bOp- to-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiances for 5 min (bOp- to-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 to reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized based on co-injected GFP intensity shown here; GFP images correspond to representative images shown in . (Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection, Staining

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). At early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiance for 5 min (bOpto-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent protein nls-Kaede and bOpto-FGF . At early gastrulation (shield) embryos were either kept in the dark (A) or illuminated locally with 405 and 445 nm confocal lasers (B,B’) . HCR-IF was used to detect ppERK. Dotted white line in B’ outlines photoconverted Kaede in embryo shown in B. ( ; Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: bioRxiv

Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

doi: 10.1101/2025.04.17.649426

Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent proteins nls-Kaede and bOpto-FGF . At early gastrulation embryos were either kept in the dark ( A-C, J-L, S-U ) or illuminated locally with 405 and 445 nm confocal lasers. HCR-IF was used to detect ppERK. Two representative exposed embryos from three repeats shown ( D-I’, M-R’, V-AA’ , respectively). Dotted white lines outline photoconverted Kaede from images to the left. A-F’ are shown in . (Scale bar is 200 µm).

Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

Techniques: Injection

Journal: Clinical oral investigations

Article Title: Recombinant human bone morphogenetic protein (rhBMP)9 induces osteoblast differentiation when combined with demineralized freeze-dried bone allografts (DFDBAs) or biphasic calcium phosphate (BCP).

doi: 10.1007/s00784-016-1983-0

Figure Lengend Snippet: Fig. 2 BMP2 and BMP9 release kinetics from a DFDBA and b BCP granules at 15 min, 1 h, 8 h, 24 h, 3 days, and 10 days after loading on each bone graft granules

Article Snippet: Briefly, after the coating period, incubation of 100 ng/ml of rhBMP2/9 onto DFDBA and BCP at 37 °C in a shaking incubator, the remaining PBS solution, containing unattached protein, was collected and quantified by an ELISA Duoset kit for BMP2 (DY355, range = 46.90–3000 pg/ml, R&D Systems) and BMP9 (DY3209, range = 15.60–1000 pg/ml, R&D Systems).

Techniques:

Journal: Scientific Reports

Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

doi: 10.1038/s41598-026-35269-z

Figure Lengend Snippet: The amount of BMP-2 in DBM significantly increased in the order of OD > MD > ID using either extracted method, and was more than cortical particles.

Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

Techniques:

Journal: Scientific Reports

Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

doi: 10.1038/s41598-026-35269-z

Figure Lengend Snippet: The trend of BMP-7 distributed in DBM and cortical particles was similar with BMP-2.

Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

Techniques:

Journal: Scientific Reports

Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

doi: 10.1038/s41598-026-35269-z

Figure Lengend Snippet: Through the linear regression analysis, the content of BMP-7 varied linearly with the content of BMP-2 (GuHCl vs. collagenase, R2 = 0.945 vs. R2 = 0.818, respectively).

Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

Techniques:

Journal: Clinical oral investigations

Article Title: Recombinant human bone morphogenetic protein (rhBMP)9 induces osteoblast differentiation when combined with demineralized freeze-dried bone allografts (DFDBAs) or biphasic calcium phosphate (BCP).

doi: 10.1007/s00784-016-1983-0

Figure Lengend Snippet: Fig. 2 BMP2 and BMP9 release kinetics from a DFDBA and b BCP granules at 15 min, 1 h, 8 h, 24 h, 3 days, and 10 days after loading on each bone graft granules

Article Snippet: Briefly, after the coating period, incubation of 100 ng/ml of rhBMP2/9 onto DFDBA and BCP at 37 °C in a shaking incubator, the remaining PBS solution, containing unattached protein, was collected and quantified by an ELISA Duoset kit for BMP2 (DY355, range = 46.90–3000 pg/ml, R&D Systems) and BMP9 (DY3209, range = 15.60–1000 pg/ml, R&D Systems).

Techniques: